Abstract
Introduction
During the past three decades, improvements in the treatment of childhood leukemia have resulted in high cure rates, particularly for acute lymphoblastic leukemia (ALL). Unfortunately, successful therapy has come with a price, as significant morbidity can result from neurological affects which harm the brain and spinal cord. The expectation and hope is that chemotherapy, as a primary means of CNS therapy, will result in acceptable disease control with less CNS morbidity than has been observed with combinations of chemotherapy and radiotherapy over the past several decades.
Methods and results
In this review we discuss the poignant, historical aspects of CNS leukemia therapy, outline current methods of systemic and CNS leukemia therapy, and present imaging findings we have encountered in childhood leukemia patients with a variety of acute neurological conditions. A major objective of our research is to understand the neuroimaging correlates of acute and chronic effects of cancer and therapy. Specific features related to CNS leukemia and associated short-term toxicities, both disease- and therapy-related, are emphasized in this review with the specific neuroimaging findings. Specific CNS findings are similarly important when treating acute myelogenous leukemia (AML), and details of leukemic involvement and toxicities are also presented in this entity.
Conclusion
Despite contemporary treatment approaches which favor the use of chemotherapy (including intrathecal therapy) over radiotherapy in the treatment of CNS leukemia, children still occasionally experience morbid neurotoxicity. Standard neuroimaging is sufficient to identify a variety of neurotoxic sequelae in children, and often suggest specific etiologies. Specific neuroimaging findings frequently indicate a need to alter antileukemia therapy. It is important to appreciate that intrathecal and high doses of systemic chemotherapy are not innocuous and are associated with acute, specific, recognizable, and often serious neurological consequences.
Similar content being viewed by others
References
Pui CH, Evans WE (2006) Treatment of acute lymphoblastic leukemia. N Engl J Med 354:166–178
Creutzig U, Zimmermann M, Ritter J, Reinhardt D, Hermann J, Henze G, Jurgens H, Kabisch H, Reiter A, Riehm H, Gadner H, Schellong G (2005) Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials. Leukemia 19:2030–2042
Gibson BE, Wheatley K, Hann IM, Stevens RF, Webb D, Hills RK, De Graaf SS, Harrison CJ (2005) Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials. Leukemia 19:2130–2138
Pui CH, Cheng C, Leung W, Rai SN, Rivera GK, Sandlund JT, Ribeiro RC, Relling MV, Kun LE, Evans WE, Hudson MM (2003) Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. N Engl J Med 349:640–649
Kun LE (2007) Leukemias in children. Pediatric Radiation Oncology 15–39
Mahmoud HH, Rivera GK, Hancock ML, Krance RA, Kun LE, Behm FG, Ribeiro RC, Sandlund JT, Crist WM, Pui CH (1993) Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia. N Engl J Med 329:314–319
Burger B, Zimmermann M, Mann G, Kuhl J, Loning L, Riehm H, Reiter A, Schrappe M (2003) Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture. J Clin Oncol 21:184–188
Price RA (1979) Histopathology of CNS leukemia and complications of therapy. Am J Pediatr Hematol Oncol 1:21–30
Pinkel D (1970) Treatment of childhood acute lymphocytic leukemia. J Pediatr 77:1089–1091
Creutzig U, Ritter J, Zimmermann M, Hermann J, Gadner H, Sawatzki DB, Niemeyer CM, Schwabe D, Selle B, Boos J, Kuhl J, Feldges A (2001) Idarubicin improves blast cell clearance during induction therapy in children with AML: results of study AML-BFM 93. AML-BFM Study Group. Leukemia 15:348–354
Krance RA, Hurwitz CA, Head DR, Raimondi SC, Behm FG, Crews KR, Srivastava DK, Mahmoud H, Roberts WM, Tong X, Blakley RL, Ribeiro RC (2001) Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases. J Clin Oncol 19:2804–2811
Woods WG, Neudorf S, Gold S, Sanders J, Buckley JD, Barnard DR, Dusenbery K, DeSwarte J, Arthur DC, Lange BJ, Kobrinsky NL (2001) A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission. Blood 97:56–62
Stevens RF, Hann IM, Wheatley K, Gray RG (1998) Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council’s 10th AML trial. MRC Childhood Leukaemia Working Party. Br J Haematol 101:130–140
Ravindranath Y, Yeager AM, Chang MN, Steuber CP, Krischer J, Graham-Pole J, Carroll A, Inoue S, Camitta B, Weinstein HJ (1996) Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group. N Engl J Med 334:1428–1434
Boulad F, Kernan NA (1993) Treatment of childhood acute nonlymphoblastic leukemia: a review. Cancer Invest 11:534–553
Lowenberg B, Downing JR, Burnett A (1999) Acute myeloid leukemia. N Engl J Med 341:1051–1062
Raimondi SC, Chang MN, Ravindranath Y, Behm FG, Gresik MV, Steuber CP, Weinstein HJ, Carroll AJ (1999) Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study – POG 8821. Blood 94:3707–3716
Bloomfield CD, Shuma C, Regal L, Philip PP, Hossfeld DK, Hagemeijer AM, Garson OM, Peterson BA, Sakurai M, Alimena G, Berger R, Rowley JD, Ruutu T, Mitelman F, Dewald GW, Swansbury J (1997) Long-term survival of patients with acute myeloid leukemia: a third follow-up of the Fourth International Workshop on Chromosomes in Leukemia. Cancer 80:2191–2198
Sievers EL, Lange BJ, Buckley JD, Smith FO, Wells DA, Igneault-Creech CA, Shults KE, Bernstein ID, Loken MR (1996) Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry. J Natl Cancer Inst 88:1483–1488
Pui CH, Dahl GV, Kalwinsky DK, Look AT, Mirro J, Dodge RK, Simone JV (1985) Central nervous system leukemia in children with acute nonlymphoblastic leukemia. Blood 66:1062–1067
Graham A, Hodgson T, Jacubowski J, Norfolk D, Smith C (2001) MRI of perineural extramedullary granulocytic sarcoma. Neuroradiology 43:492–495
Kingsley DP, Kendall BE (1978) Cranial computed tomography in leukaemia. Neuroradiology 16:543–546
Kitajima M, Korogi Y, Shigematsu Y, Liang L, Matsuoka M, Yamamoto T, Jhono M, Eto K, Takahashi M (2002) Central nervous system lesions in adult T-cell leukemia: MRI and pathology. Neuroradiology 44:559–567
Majhail NS, Lichtin AE (2004) Acute leukemia with a very high leukocyte count: confronting a medical emergency. Cleve Clin J Med 71:633–637
Chen CY, Zimmerman RA, Faro S, Bilaniuk LT, Chou TY, Molloy PT (1996) Childhood leukemia: central nervous system abnormalities during and after treatment. AJNR Am J Neuroradiol 17:295–310
Eguiguren JM, Schell MJ, Crist WM, Kunkel K, Rivera GK (1992) Complications and outcome in childhood acute lymphoblastic leukemia with hyperleukocytosis. Blood 79:871–875
Lowe EJ, Pui CH, Hancock ML, Geiger TL, Khan RB, Sandlund JT (2005) Early complications in children with acute lymphoblastic leukemia presenting with hyperleukocytosis. Pediatr Blood Cancer 45:10–15
Neglia JP, Robison LL, Stovall M, Liu Y, Packer RJ, Hammond S, Yasui Y, Kasper CE, Mertens AC, Donaldson SS, Meadows AT, Inskip PD (2006) New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 98:1528–1537
Paakko E, Talvensaari K, Pyhtinen J, Lanning M (1999) Late cranial magnetic resonance imaging after cranial irradiation in survivors of childhood cancer. Neuroradiology 36:652–655
Rollins N, Winick N, Bash R, Booth T (2004) Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcome. AJNR Am J Neuroradiol 25:1688–1695
Mahoney DH Jr, Shuster JJ, Nitschke R, Lauer SJ, Steuber CP, Winick N, Camitta B (1998) Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy – a Pediatric Oncology Group study. J Clin Oncol 16:1712–1722
Pui CH, Evans WE (1999) Acute lymphoblastic leukemia in infants. J Clin Oncol 17:438–440
Winick NJ, Bowman WP, Kamen BA, Roach ES, Rollins N, Jacaruso D, Buchanan GR (1992) Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia. J Natl Cancer Inst 84:252–256
Pedersen H, Clausen N (1981) The development of cerebral CT changes during treatment of acute lymphocytic leukemia in childhood. Neuroradiology 22:79–84
Morgan GW, Barohn RJ, Bazan C III, King RB, Klucznik RP (1993) Nerve root enhancement with MRI in inflammatory demyelinating polyradiculoneuropathy. Neurology 43:618–620
Georgy BA, Chong B, Chamberlain M, Hesselink JR, Cheung G (1994) MR of the spine in Guillain-Barre syndrome. AJNR Am J Neuroradiol 15:300–301
Paakko E, Vainionpaa L, Phytinen J, Lanning M (1996) Minor changes on cranial MRI during treatment in children with acute lymphoblastic leukaemia. Neuroradiology 38:264–268
Caruso V, Iacoviello L, Di Castelnuovo A, Storti S, Mariani G, de Gaetano G, Donati MB (2006) Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients. Blood 108:2216–2222
Morris EB, Laningham FH, Sandlund JT, Khan RB (2007) Posterior reversible encephalopathy syndrome in children with cancer. Pediatr Blood Cancer 48:152–159
Conflict of interest statement
We declare that we have no conflict of interest.
Acknowledgements
This work was supported in part by Cancer Center Core Grant CA (21765) and the American Lebanese Syrian Associated Charities (ALSAC).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Laningham, F.H., Kun, L.E., Reddick, W.E. et al. Childhood central nervous system leukemia: historical perspectives, current therapy, and acute neurological sequelae. Neuroradiology 49, 873–888 (2007). https://doi.org/10.1007/s00234-007-0300-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00234-007-0300-7